Francoise de Craecker - 14 Oct 2021 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Director
Signature
Derek Meisner, attorney-in-fact
Issuer symbol
XFOR
Transactions as of
14 Oct 2021
Net transactions value
$0
Form type
4
Filing time
18 Oct 2021, 16:15:52 UTC
Next filing
27 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XFOR Stock Option (right to buy) Award $0 +12,250 $0.000000 12,250 14 Oct 2021 Common Stock 12,250 $5.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33.3333% of the shares subject to the option shall vest on October 14, 2022, with the remainder vesting thereafter in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.